SCHEMBL1155702

SCHEMBL1155702

C1=CC2CC[N]CC2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1054620 0.69
SCHEMBL1576131 0.68
SCHEMBL14534464 0.64
SCHEMBL831131 0.64 ALDH1A1 (0.32)
SCHEMBL22037 0.64
SCHEMBL9048349 0.63
SCHEMBL2012202 0.62
SCHEMBL9050227 0.62
SCHEMBL5462876 0.62
SCHEMBL122550 0.61 ALDH1A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 577 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024095003-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2024-05-10 WO claimed
US-8536195-B2 Bicyclic derivatives as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-09-17 US claimed
US-20130084639-A1 Bicyclic Derivatives as Modulators of Ion Channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-04-04 US claimed
US-8362032-B2 Bicyclic derivatives as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-29 US claimed
EP-1720835-B1 NOVEL GUANIDINYL-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AS EFFECTIVE PHOSPHODIESTERASE (PDE) 4 INHIBITORS NYCOMED GMBH (DE) 2012-12-12 EP claimed
US-8314125-B2 Bicyclic derivatives as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-11-20 US claimed
EP-1891063-B1 BICYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2012-07-25 EP claimed
EP-1888558-B1 BICYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2011-10-05 EP claimed
US-7989481-B2 Indane derivatives as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-08-02 US claimed
JP-4728259-B2 2011-07-20 JP claimed
WO-1999032466-A1 SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE NOVARTIS AG (CH) 1999-07-01 WO claimed
WO-1999007672-A1 DERIVATIVES OF 2,5- AND 3,5-DISUBSTITUTED ANILINES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1999-02-18 WO claimed
WO-1998047523-A1 PEPTIDYL-2-AMINO-1-HYDROXYALKANESULFONIC ACID CYSTEINE PROTEASE INHIBITORS CEPHALON INC. (US) 1998-10-29 WO claimed
US-5663183-A CEREBRAL DISORDERS SYNTHELABO (FR) 1997-09-02 US claimed
WO-1996033718-A1 AGENT FOR SEVERE ACUTE PANCREATITIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-10-31 WO claimed
EP-0213006-B1 DERIVATIVES OF 2,3-DIHYDRO-BENZOFURANE, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ADIR ET COMPAGNIE (FR) 1989-01-25 EP claimed
EP-0213006-A1 Derivatives of 2,3-dihydro-benzofurane, processes for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1987-03-04 EP claimed
EP-0063826-B1 2-AMINO-BENZOIC-ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES OR INTERMEDIATES Dr. Karl Thomae GmbH (DE) 1984-12-05 EP claimed
EP-0063826-A2 2-Amino-benzoic-acid derivatives, their preparation and their use as medicines or intermediates Dr. Karl Thomae GmbH (DE) 1982-11-03 EP claimed
EP-0023569-A1 Derivatives of carboxylic acids, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1981-02-11 EP claimed